Translations:Anti-obesity medication/25/ja: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Obesity/ja}} {{Antiobesity preparations/ja}} {{Major drug groups/ja}} {{Portal bar | Medicine}}" |
(No difference)
|
Latest revision as of 18:27, 7 March 2024
主要な化学薬品グループ - 解剖学的治療化学分類法に基づく | |
|---|---|
| 消化管 / metabolism/ja (A) | |
| 血液と血液 生成器官 (B) | |
| 循環器系 (C) | |
| 皮膚 (D) | |
| 泌尿生殖器系 (G) | |
| 内分泌器 (H) | |
| infection/ja と 万延 (J, P, QI) | |
| malignant/ja疾患 (L01–L02) | |
| 免疫疾患 (L03–L04) | |
| muscle/ja, bone/ja, とjoint/ja (M) | |
| 脳と神経 (N) |
|
| 呼吸器 (R) | |
| 感覚器 (S) | |
| 他のATC (V) | |
